In humans and other multicellular organisms, cells multiply. This defining feature allows embryos to grow into adulthood, and ...

POLG-related diseases disrupt the function of the mitochondria, or "powerhouses" of the cell — starving them of energy.

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Researchers from Columbia University and the German Cancer Center have found that stellate cells—star-shaped liver cells long ...

A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...

The discovery of ‘ovoid cells’ is transforming our understanding of memory and may pave the way for new treatments for ...

Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key ...

Using a new brain mapping method, researchers found that specific memory cells in the hippocampus are highly susceptible to ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Diagnosis of PDB is a combination of clinical evaluation, imaging and histopathological assessment. If an underlying cancer ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein ...